Recommendations for advancing development of acute stroke therapies - Stroke Therapy Academic Industry Roundtable 3

被引:141
作者
Fisher, M [1 ]
机构
[1] Univ Massachusetts, Mem Healthcare, Dept Neurol, Worcester, MA 01605 USA
关键词
clinical trials; drug therapy; combination; patient selection; stroke management;
D O I
10.1161/01.STR.0000072983.64326.53
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background-The development of acute stroke therapy has proven to be a daunting task, with a few successful and many unsuccessful trials. New strategies need to be considered to enhance the chances for success in future trials. Summary of Review-The third Stroke Therapy Academic Industry Roundtable (STAIR) conference focused on issues related to increasing the percentage of acute stroke patients who might be included in acute stroke therapy trials and ultimately treated with drugs proven to be effective. A second focus was directed at the need for implementing multimodality stroke trials and potential ways to organize such trials in the near future. Finally, concepts for organizing and implementing acute stroke trials that incorporate current, state of the art trial methodology were discussed. Conclusions-It is hoped that these suggestions will enhance future stroke trials and the development of effective, new acute stroke treatments that are maximally effective and utilized.
引用
收藏
页码:1539 / 1546
页数:8
相关论文
共 83 条
[31]   Combination therapy stroke trial: Recombinant tissue-type plasminogen activator with/without lubeluzole [J].
Grotta, J .
CEREBROVASCULAR DISEASES, 2001, 12 (03) :258-263
[32]   Which targets are relevant for therapy of acute ischemic stroke? [J].
Heiss, WD ;
Thiel, A ;
Grond, M ;
Graf, R .
STROKE, 1999, 30 (07) :1486-1489
[33]   PROGRESSIVE DERANGEMENT OF PERIINFARCT VIABLE TISSUE IN ISCHEMIC STROKE [J].
HEISS, WD ;
HUBER, M ;
FINK, GR ;
HERHOLZ, K ;
PIETRZYK, U ;
WAGNER, R ;
WIENHARD, K .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (02) :193-203
[34]  
Holzer M, 2002, NEW ENGL J MED, V346, P549
[35]   Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome - Part 2 [J].
Jacobs, MA ;
Mitsias, P ;
Soltanian-Zadeh, H ;
Santhakumar, S ;
Ghanei, A ;
Hammond, R ;
Peck, DJ ;
Chopp, M ;
Patel, S .
STROKE, 2001, 32 (04) :950-957
[36]  
Jennison C., 2000, GROUP SEQUENTIAL MET
[37]   Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[38]   Ischemic core and penumbra in human stroke [J].
Kaufmann, AM ;
Firlik, AD ;
Fukui, MB ;
Wechsler, LR ;
Jungries, CA ;
Yonas, H .
STROKE, 1999, 30 (01) :93-99
[39]   Advances in neuroimaging of acute stroke [J].
Kidwell C.S. ;
Villablanca J.P. ;
Saver J.L. .
Current Atherosclerosis Reports, 2000, 2 (2) :126-135
[40]  
Kidwell CS, 2000, ANN NEUROL, V47, P462, DOI 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.0.CO